Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again?
5-aminosalicylic acid (5-ASA) preparations (eg, mesalazine, mesalamine) are well-established preparations used in the management of inflammatory bowel disease. These drugs are most useful for the treatment of mild to moderate flares of ulcerative colitis and, especially, for maintenance of remission...
Saved in:
Main Authors: | Marietta Iacucci, Shanika de Silva, Subrata Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2010/586092 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should We Establish Standards of Care for Management of Elderly Patients with Inflammatory Bowel Disease?
by: Subrata Ghosh, et al.
Published: (2015-01-01) -
Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease
by: Lik Hang Lee, et al.
Published: (2017-01-01) -
Once Again on ʾbk wdm in Ethiopian Sabaic
by: Aaron Michael Butts, et al.
Published: (2023-03-01) -
Routine Duodenal Biopsies to Diagnose Celiac Disease
by: Marietta Iacucci, et al.
Published: (2013-01-01) -
Drug therapy: dose-response relationship of oral mesalazine in
inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01)